Sectors
Recruit Holdings participated in CleverTap’s $105m series D round while Liberty Media led a $100m series D for sports media platform Overtime.
Legend Capital-backed MicuRx has floated on the Shanghai Stock Exchange and Intel Capital took part in Geek+’s $100m series E1 round.
Every day, Global Corporate Venturing rounds up the news from across the corporate innovation ecosystem.
Every day, Global Corporate Venturing rounds up the news from across the corporate innovation ecosystem.
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
The Takeda Vaccines spinoff floated in an upsized offering that granted its former parent $100m in shares.
The Sinopharm-backed laboratory animal model developer floated on Shanghai Stock Exchange’s Star Market two years after its last equity funding.
Tigermed, Fosun, Haisco and Sinopharm-CICC all scored exits as the oncology and metabolic disorder therapeutics went public in China.
The Macrogen-backed gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
